Silent period

In its communication, FIT Biotech observes a silent period beginning 30 days prior to the publication of the half-year interim report and the financial statements release and ending at the moment of publication of the interim report or financial statements release. During the silent period, FIT Biotech does not comment on the company’s financial situation, the market or future outlook. During the silent period, the management of FIT Biotech does not meet representatives of the capital markets or financial media or comment on the company’s financial situation or general business issues. The silent periods are specified in FIT Biotech’s investor calendar on the website.